Received Nov 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLUCELVAX) | SEQIRUS, INC. | UNK | 409411 | IM / LA |
Patient fainted within 10-15 seconds after receiving flu vaccine. Immediately patient was placed flat on his back on the floor with his legs raised on chair. During this time patient had lost consciousness. After 10-20 seconds, patient regained consciousness but remained in the same position. During this time, patient was able to respond and communicate, and he was able to answer personal identifying questions. Patient requested and was provided bottle of water and ice-pack after he complained of feeling hot. After about 10 minutes, patient sat down on a chair. He complained that his legs felt a little weak. He was encouraged to remain seated during which time he was actively looking on his phone and talking to his mother and brother. Eventually, after 20-30 minutes from the start of incident, patient was able to walk out of the pharmacy. We followed up with patient?s mom on 11/06/2025 and confirmed patient is doing okay. Patient is known to pharmacy and according to his mother he has a history of passing out after receiving a vaccine. While patient did not pass out the two times we administered flu vaccine to him in previous years (2023 and 2024), he did faint this time around.
N/A
N/A
N/A
Sulfa (Sulfonamide antibiotics)